Eaton Vance Management Boston Scientific Corp Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Boston Scientific Corp stock. As of the latest transaction made, Eaton Vance Management holds 4,388,082 shares of BSX stock, worth $451 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

4,388,082

Previous 4,293,732 2.2%

Holding current value

$451 Million

Previous $160 Million 6.2%

% of portfolio

0.25%

Previous 0.22%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $3.46 Million - $10.3 Million	94,350 Added 2.2%	4,388,082 $170 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $6.15 Million - $8.21 Million	174,401 Added 4.23%	4,293,732 $160 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $14.4 Million - $15.9 Million	351,663 Added 9.33%	4,119,331 $182 Million
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $7.31 Million - $8.61 Million	-191,949 Reduced 4.85%	3,767,668 $159 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $6.67 Million - $7.43 Million	-161,891 Reduced 3.93%	3,959,617 $171 Million

Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $15.6 Million - $17.9 Million	-403,501 Reduced 8.92%	4,121,508 $176 Million
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $34.8 Million - $39.1 Million	-986,030 Reduced 17.89%	4,525,009 $175 Million
Q4 2020 Feb 12, 2021	SELL	$33.15 - $41.97 $39 Million - $49.4 Million	-1,177,689 Reduced 17.61%	5,511,039 $198 Million
Q3 2020 Nov 13, 2020	BUY	$34.44 - $42.23 $15 Million - $18.4 Million	436,567 Added 6.98%	6,688,728 $256 Million
Q2 2020 Nov 20, 2020	BUY	$30.19 - $39.11 $2.01 Million - $2.61 Million	66,731 Added 1.08%	6,252,161 $220 Million
Q2 2020 Aug 13, 2020	BUY	$30.19 - $39.11 $105 Million - $136 Million	3,488,502 Added 129.35%	6,185,430 $217 Million
Q1 2020 May 14, 2020	SELL	$25.83 - $45.71 $17.4 Million - $30.8 Million	-674,291 Reduced 20.0%	2,696,928 $88.1 Million
Q4 2019 Feb 11, 2020	BUY	$37.87 - $45.37 $9.99 Million - $12 Million	263,848 Added 8.49%	3,371,219 $152 Million
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $18.9 Million - $20.4 Million	469,328 Added 17.79%	3,107,371 $126 Million
Q2 2019 Nov 21, 2019	SELL	$34.91 - $42.98 $2.03 Million - $2.5 Million	-58,230 Reduced 2.16%	2,638,043 $113 Million
Q2 2019 Aug 16, 2019	BUY	$34.91 - $42.98 $5.98 Million - $7.36 Million	171,178 Added 6.78%	2,696,273 $115 Million
Q1 2019 May 14, 2019	SELL	$32.91 - $40.75 $42.1 Million - $52.2 Million	-1,279,818 Reduced 33.64%	2,525,095 $96.9 Million
Q4 2018 Feb 07, 2019	SELL	$31.73 - $39.04 $48.5 Million - $59.7 Million	-1,530,062 Reduced 28.68%	3,804,913 $134 Million
Q3 2018 Nov 13, 2018	SELL	$32.83 - $38.63 $12.4 Million - $14.6 Million	-378,768 Reduced 6.63%	5,334,975 $205 Million
Q2 2018 Aug 10, 2018	SELL	$26.84 - $34.32 $22.8 Million - $29.2 Million	-850,874 Reduced 12.96%	5,713,743 $187 Million
Q1 2018 May 07, 2018	BUY	$25.2 - $28.54 $49.2 Million - $55.7 Million	1,951,777 Added 42.31%	6,564,617 $179 Million
Q4 2017 Feb 12, 2018	BUY	$24.79 - $29.8 $30.6 Million - $36.8 Million	1,235,921 Added 36.6%	4,612,840 $114 Million
Q3 2017 Nov 13, 2017	BUY	$26.26 - $29.17 $88.7 Million - $98.5 Million	3,376,919	3,376,919 $98.5 Million

Others Institutions Holding BSX

# of Institutions

1,947

Shares Held

1.26B

Call Options Held

10.8M

Put Options Held

8.94M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $147B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Boston Scientific Corp Transaction History